Small projects offering anti-retroviral treatment have been set up countrywide. But there is need for co-ordination. Kerry Cullinan reports.

The Medicines Control Council held an urgent council meeting on the 5th of November, following its receipt in October of an interim report from America'€™s National Institutes of Health (NIH) on the on-going review programme of nevirapine. The report, received more than a month later than expected, provides details of Phase One of the two-stage investigation. In the following report by Khopotso Bodibe, the Registrar of Medicines Precious Matsoso, couldn'€™t reveal details of the council meeting, nor the contents of the preliminary report from the NIH, citing a secrecy agreement.